Testing yourself is an effective way to enhance your knowledge and become familiar with the ALS-Con-201 exam format. Rather than viewing the ALS-Con-201 test as a potentially intimidating event, VCEEngine Salesforce Certified Agentforce Life Sciences Consultant (ALS-Con-201) desktop and web-based practice exams help candidates assess and improve their knowledge. If your ALS-Con-201 Practice Exams (desktop and web-based) results aren't ideal, it's better to experience that shock during a mock exam rather than the ALS-Con-201 actual test.
| Certification Vendor: | Salesforce |
|---|---|
| Exam Name: | Salesforce Certified Agentforce Life Sciences Consultant |
| Exam Number: | ALS-Con-201 |
| Exam Price: | US$200 |
| Available Languages: | English |
| Certificate Validity Period: | 2 years |
| Passing Score: | 62% |
| Exam Format: | Scenario-based, Multiple-choice |
| Related Certifications: | Salesforce Certified Platform Administrator |
| Exam Duration: | 105 minutes |
| Real Exam Qty: | 60-65 |
| Recommended Training: | Agentforce Life Sciences Consultant Certification Preparation |
| Exam Registration: | Salesforce Certification Registration |
| Sample Questions: | Salesforce ALS-Con-201 Sample Questions |
| Exam Way: | Online proctored or onsite testing center |
| Pre Condition: | Hold Salesforce Certified Platform Administrator certification; at least 1 year experience in life sciences industry; at least 6 months hands-on experience configuring Agentforce Life Sciences |
| Official Syllabus URL: | https://help.salesforce.com/s/articleView?id=005305357&language=en_US |
>> Valid ALS-Con-201 Exam Testking <<
Our ALS-Con-201 study materials have plenty of advantages. For example, in order to meet the needs of different groups of people, we provide customers with three different versions of ALS-Con-201 study materials, which contain the same questions and answers. You can choose the one that best suits you according to your study habits. Secondly, the passing rate of our ALS-Con-201 Study Materials is very high. Generally speaking, 98 % - 99 % of the users can successfully pass the exam, obtaining the corresponding certificate.
| Topic | Details |
|---|---|
| Topic 1 |
|
| Topic 2 |
|
| Topic 3 |
|
| Topic 4 |
|
NEW QUESTION # 53
Choose 1 option.
Cumulus Pharma uses Agentforce Life Sciences for Customer Engagement to provide Account Summaries. The Agentforce Life Sciences Consultant configured a Cross-Object Field History Graph to include related Provider Visit and Medical Inquiry records. Key Account Managers report that summaries include all related data; however, field sales reps report that their summaries exclude visit and inquiry data. Both user groups have Read access to the underlying objects.
What is the cause of this issue?
Answer: A
Explanation:
The correct answer is A because Account Summarization can use different Cross-Object Field History Graph assignments by org or profile. Salesforce Help for Life Sciences Account Summarization states that administrators can create a Cross-Object Graph for Account Summarization and assign cross-object graphs to an org or profile. Salesforce also describes the Account Summarization workflow as using configured cross-object field history so summaries can include recent and relevant account changes from related objects.
In this case, KAMs see summaries that include Provider Visit and Medical Inquiry records, while field sales reps do not. Both groups have Read access to the objects, so object permission is not the root cause. The difference is most likely profile-based summarization configuration: the graph containing Provider Visit and Medical Inquiry data has been assigned to the KAM profile but not to the field sales rep profile.
Option B is incorrect because Account Summary generation in this scenario is driven by Cross-Object Field History Graph configuration, not membership in a Data 360 segment. Option C is also incorrect because the question explicitly says both user groups have Read access. View All is not the stated requirement for using a graph in summarization. Therefore, the issue is that the Cross-Object Field History Graph is not assigned to the field sales rep profile.
=========
NEW QUESTION # 54
Choose 1 option.
Cumulus Pharma has a unique record for a Healthcare Provider (HCP). During a visit, a field sales rep captures another address in Contact Point Address and marks it as primary, without updating the existing address record that is already marked as primary. The company's admin has scheduled the out-of-the-box Account Address batch jobs to run nightly.
Which record will the job use as primary?
Answer: B
Explanation:
The correct answer is C because the out-of-the-box Account Address batch job resolves duplicate primary Contact Point Address records by using the last modified record that is marked as primary. Salesforce Help for Life Sciences Account Address batch jobs states that if multiple Contact Point Address records are marked as primary, the job uses the last modified record marked as primary. This directly matches the scenario where the sales rep creates or updates another Contact Point Address and marks it as primary while the previous primary address remains unchanged.
Because both address records are now marked as primary, the batch job must determine which one should be treated as the effective primary address. Since the newly captured address was modified most recently and is marked as primary, the nightly Account Address batch job will use that last modified primary record. This behavior helps Life Sciences Cloud maintain a consistent primary-address reference when conflicting primary flags exist.
Option A is incorrect because the previous primary record is no longer the most recently modified primary record. The system does not automatically prefer the older record simply because it was primary first. Option B is incorrect because the newly captured record is not non-primary; the rep explicitly marked it as primary. The rule applies to records marked as primary, and among those records, the most recently modified one is selected. Therefore, the batch job will use the last modified record.
=========
NEW QUESTION # 55
Choose 1 option.
Cumulus Pharma's field sales reps use the Medical Insights feature in Agentforce Life Sciences for Customer Engagement to record insights from their engagements with Healthcare Providers (HCPs). The VP of Customer Engagement wants the reps to provide feedback on the medical insights captured.
Which object should an Agentforce Life Sciences Consultant recommend?
Answer: A
Explanation:
The correct answer is A because User Reaction is the object designed to capture user feedback or reactions related to a Medical Insight. Salesforce's Life Sciences Cloud Developer Guide identifies the UserReaction object and states that it can be associated with a medical insight through the source reference record relationship. This makes it the most appropriate object when users need to provide feedback on Medical Insights that have already been captured.
The scenario is not asking field reps to complete a formal assessment or collect HCP feedback. It asks for reps to provide feedback on the medical insights captured in the system. A User Reaction record supports this by allowing a user-level response to be connected back to the relevant Medical Insight record, preserving the relationship between the insight and the feedback.
Option B, Assessment Task, is incorrect because assessment tasks are typically used as structured tasks or questionnaires within planning, account management, or guided evaluation workflows. They are not the direct object for providing reactions to Medical Insights. Option C, Survey, is also incorrect because surveys are used to collect responses, often from customers or HCPs, through a survey experience. A survey would be unnecessary and less precise for internal rep feedback on an existing Medical Insight. Therefore, User Reaction is the correct object to recommend.
=========
NEW QUESTION # 56
Choose 1 option.
Cumulus Pharma uses Agentforce Account Summary to provide the latest and most relevant account information before each Healthcare Provider (HCP) interaction. The company is onboarding a new persona for its Key Account Managers (KAMs). Provider account summaries generated for this new persona need information from two additional custom objects that store insights and market intelligence.
Which configuration ensures the new information is used only while generating the provider summary for this new persona?
Answer: B
Explanation:
Option A is correct because Account Summarization uses cross-object graphs to determine which related objects and relationships are included in generated summaries. Salesforce Life Sciences Account Summarization setup resources reference creating a cross-object graph for Account Summarization and assigning cross-object graphs to an org or profile. This supports persona-specific summary behavior because a graph can be configured with the additional custom objects and then assigned specifically to the KAM profile.
The requirement says the new information must be used only for the new KAM persona. That means the consultant should avoid changing the default or shared provider summary mapping used by other personas. By creating a separate cross-object graph from the template, adding the two custom insight and market-intelligence objects, and assigning that graph only to the KAM profile, the consultant isolates the new summary structure to the intended users.
Option B is not the best answer because globally updating Provider Summary Objects mapping could affect more than the KAM persona if the mapping is shared. Option C is also not the best answer because the key Account Summarization configuration pattern documented by Salesforce is graph creation and graph assignment to an org or profile. Therefore, the correct configuration is to create a new cross-object graph and assign it to the KAM profile.
=========
NEW QUESTION # 57
Choose 1 option.
Cumulus Pharma is preparing for the commercial launch of a new product, "Immunexis." The sales operations director wants to implement a strategic sampling control that is not required by law, but is critical for inventory management. The requirements for this rule are:
Period Logic: The limit period must dynamically begin on the Product Launch Date rather than the standard Calendar Year.
Enforcement: To avoid blocking sales momentum, the system must only display a warning, or soft limit, if a rep exceeds the allocated quantity, allowing the rep to proceed with the disbursement if necessary.
Which Sample Limit Template type meets these requirements?
Answer: B
Explanation:
Option C is correct because Advanced Sample Limit Templates are designed for custom, complex sample-limit rules. Salesforce Help explains that advanced sample limit templates are used to define custom sample limit rules for more complex needs and stricter requirements. This scenario requires two non-basic behaviors: a dynamic period start based on the product launch date and soft-limit enforcement that warns the rep but still allows the disbursement to proceed. Those requirements go beyond a generic calendar-year rule.
A Generic Sample Limit Template is not the best answer because generic templates are better suited for standard sample-limit logic. The requirement explicitly says the limit period must begin on the Product Launch Date rather than the standard Calendar Year, which makes the rule more specialized. A Country Sample Limit Template is also not correct because country templates are used for country-specific legal or regulatory sampling limits. In this question, the control is strategic and inventory-driven, not a legal requirement tied to a specific country.
Advanced templates are the correct fit because they allow more flexible configuration for business-specific sample controls, including nonstandard periods and warning-based enforcement. Therefore, the consultant should use an Advanced Sample Limit Template for the Immunexis launch sampling rule.
=========
NEW QUESTION # 58
......
Sample ALS-Con-201 Questions Pdf: https://www.vceengine.com/ALS-Con-201-vce-test-engine.html